Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal Cancers 2024-06-05 19:00
FDA Approved Phase II/III Clinical Study of KPG-121 in Combination with Abiraterone as a First Line Treatment for mCRPC 2024-06-05 19:00
Waterdrop Inc. Announces First Quarter 2024 Unaudited Financial Results 2024-06-05 18:00
Perfect Diary's Parent Company Yatsen Group Officially Unveils Global Innovation and R&D Center 2024-06-05 17:00
GC Genome Highlights Promising New Approach for Non-invasive Colorectal Cancer Detection at ASCO 2024 2024-06-05 14:00
Live from ASCO 2024 | Oral Report Released Latest Data of Olverembatinib in SDH-Deficient GIST, Including a CBR of 92.3% 2024-06-05 11:46
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data Showing Promising Efficacy and Safety of Lisaftoclax in Patients with WM 2024-06-05 11:31
CARsgen Presents Updated Results on Satri-cel in Nature Medicine and at 2024 ASCO 2024-06-04 20:50
FDA Clearance For Gastrointestinal Parasite Detection Kit 2024-06-04 19:00
MicroAlgo Inc. (NASDAQ: MLGO) Announced to Jointly Establish a Micro-Consciousness Quantum Research Center With WIMI (NASDAQ: WIMI) 2024-06-04 16:10
Qingsong Health Corporation Elevates Healthcare and Inclusive Development with AI Advancements at WSIS+20 Forum 2024-06-04 16:04
GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings 2024-06-04 13:00
Live from ASCO 2024 | Updated Data of Bcl-2 Inhibitor Lisaftoclax Combined with Azacitidine in Patients with AML Demonstrate Promising Efficacy and Manageable Safety 2024-06-04 12:51
Fapon Biopharma Announces a Safer Immunotherapy for Cancers 2024-06-04 09:42
Datasea Agreement already provided $2.8 million Information Service for its Highly Specialized 5G-AI Communications Platform 2024-06-03 22:00
Minghui Pharmaceutical Presents Phase 1/2 Clinical Data of MHB088C (B7-H3 ADC) as Monotherapy for the Treatment of Patients with Recurrent or Metastatic Solid Tumors at the 2024 ASCO Annual Meeting 2024-06-03 21:30
Visionary Pioneering Innovation Across Four Key Frontiers 2024-06-03 20:30
Psylo Announces First Close on $8 Million Series Seed Financing to Advance Next-Generation Neuroplastogens at BIO Conference in San Diego 2024-06-03 20:00
Formosa Laboratories Completes the Acquisition of Synchem to Expand North American CDMO Footprint 2024-06-03 13:01
MGI Tech's DNBSEQ-E25 and G99 Platforms Set Record for Sequencing Applications on Mount Everest 2024-06-03 11:35
1 28 29 30 31 32 812